Literature DB >> 18353638

Synthesis and biological evaluation of 3,5-diaminoindazoles as cyclin-dependent kinase inhibitors.

Jinho Lee1, Hwangeun Choi, Kyoung-Hee Kim, Shinwu Jeong, Jong-Wook Park, Chul-Su Baek, Sei-Hee Lee.   

Abstract

A novel series of 3,5-diaminoindazoles were prepared and found to be CDK inhibitors. Potent inhibitors against CDK1 and CDK2 were obtained by introduction of 1lambda(6)-isothiazolidine-1,1-dioxide at 5-position of indazole. Anti-proliferative activities of compounds were evaluated using EJ, HCT116, SW620, and A549 cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18353638     DOI: 10.1016/j.bmcl.2008.03.002

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Unprecedented rearrangement of 2-(2-aminoethyl)-1-aryl-3,4-dihydropyrazino[1,2-b]indazole-2-ium 6-oxides to 2,3-dihydro-1H-imidazo[1,2-b]indazoles.

Authors:  Jan Kocí; Allen G Oliver; Viktor Krchnák
Journal:  J Org Chem       Date:  2010-01-15       Impact factor: 4.354

2.  Remarkably efficient synthesis of 2H-indazole 1-oxides and 2H-indazoles via tandem carbon-carbon followed by nitrogen-nitrogen bond formation.

Authors:  Isabelle Bouillon; Jaroslav Zajícek; Nadĕzda Pudelová; Viktor Krchnák
Journal:  J Org Chem       Date:  2008-10-21       Impact factor: 4.354

3.  Molecular dynamics and QM/MM-based 3D interaction analyses of cyclin-E inhibitors.

Authors:  Farhan Ahmad Pasha; Mohammad Morshed Neaz
Journal:  J Mol Model       Date:  2012-10-20       Impact factor: 1.810

4.  Synthesis and anti-proliferative activity evaluation of N3-acyl-N5-aryl-3,5-diaminoindazole analogues as anti-head and neck cancer agent.

Authors:  Jinho Lee; Jina Kim; Victor Sukbong Hong; Jong-Wook Park
Journal:  Daru       Date:  2014-01-06       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.